series-c-plus
Stage
1
Investors
About
OriGene Technologies, Inc. develops and supplies research reagents including cDNA clones, antibodies, recombinant proteins, and viral delivery systems to support genomic and proteomic scientific research.
Explore OriGene Technologies, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.